Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0HB0 stock hub

LON/0HB0 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0HB0is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0HB0

In the news

Latest news · LON/0HB0

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-32.8

P25 -54.2P50 2.1P75 13.7

ROIC-120.9

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0HB0 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

167

Groups with data

Currency

USD

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	540
Employees Change	102%
Employees Change Percent	26.42
Enterprise value	$471.9M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US00847X1046
Last refreshed	2026-05-10
Market cap	$1.2B
Price	$27.99
Price currency	USD
Rev Per Employee	92,626.82x
Sector	Healthcare
Sic	2836
Symbol	lon/0HB0
Website	https://www.agios.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-26.39%
EV Earnings	-1.47x
EV/FCF	-1.62x
EV/Sales	9.73x
FCF yield	-24.02%
P/B ratio	1.44x
P/S ratio	24.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-218.5M
Net Income	$-320M
Net Income Growth Years	0%
Pretax Margin	-641.38%
Profit Per Employee	$-592,665
ROA	-21.69
Roa5y	-20.34
ROCE	-42.23
ROE	-32.82
Roe5y	-14.25
ROIC	-120.9
Roic5y	-138.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-1.86%
Cagr3y	1.96%
Cagr5y	-12.34%
EPS Growth Years	0
Revenue Growth	78.34x
Revenue Growth Q	137.75x
Revenue Growth Quarters	13x
Revenue Growth Years	3x
Revenue Growth3 Y	51.44x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.05
Assets	$897.4M
Cash	$558.2M
Current Assets	$612.4M
Current Liabilities	$43.2M
Debt	$27.1M
Debt Equity	$0.03
Debt FCF	$-0.09
Equity	$839.9M
Liabilities	$57.5M
Long Term Assets	$285M
Long Term Liabilities	$14.3M
Net Cash	$764.7M
Net Cash By Market Cap	$63.05
Net Cash Growth	-26.39%
Net Debt Equity	$-0.91
Tangible Book Value	$839.9M
Tangible Book Value Per Share	$14.15
WACC	7.26

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.19
Inventory Turnover	10.96
Net Working Capital	$43.7M
Quick ratio	12.8
Working Capital	$587.7M
Working Capital Turnover	$0.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-1.86%
200-day SMA	33.02
3Y total return	6%
50-day SMA	29.41
50-day SMA vs 200-day SMA	50under200
5Y total return	-48.22%
All Time High	92.63
All Time High Change	-69.78%
All Time High Date	2018-07-19
All Time Low	17.09
All Time Low Change	63.76%
All Time Low Date	2022-06-14
ATR	1.41
Beta	0.58
Ch YTD	3.2
High	28.02
High52	45.81
High52 Date	2025-11-18
High52ch	-38.9%
Low	27.21
Low52	22.4
Low52 Date	2025-11-20
Low52ch	24.96%
Ma50ch	-4.83%
Price vs 200-day SMA	-15.24%
RSI	47.69
RSI Monthly	44.74
RSI Weekly	46
Sharpe ratio	0.45x
Sortino ratio	0.62
Total Return	-0.25%
Tr YTD	3.2
Tr1m	-19.68%
Tr1w	-0.57%
Tr3m	3.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-360.1M
Operating margin	-720

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	50,618,619%
Shares Insiders	1.11%
Shares Institutions	94.43%
Shares Qo Q	0.74%
Shares Yo Y	0.25%
Short Ratio	6.66

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-334.3M
Average Volume	2,354.95x
Bv Per Share	14.15
CAPEX	$-3.3M
Ch1m	-19.68
Ch1w	-0.57
Ch1y	-1.86
Ch3m	3.82
Ch3y	6
Ch5y	-48.22
Ch6m	-30.89
Change	3.13%
Change From Open	2.87
Close	27.14
Days Gap	0.26
Depreciation Amortization	3,859,750.7
Dollar Volume	15,170.6
Earnings Date	2026-04-29
EBIT	$-360.1M
EBITDA	$-356.1M
EPS	$-5.49
F Score	3
FCF	$-291.4M
FCF EV Yield	-61.75x
Financing CF	6,917,981
Fiscal Year End	December
Founded	2,007
Income Tax	$-769,422
Investing CF	307,396,915
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Ma150	31.56
Ma150ch	-11.31%
Ma20	28.56
Ma20ch	-1.99%
Net CF	26,230,016
Open	27.21
Position In Range	96.3
Ppne	27,698,955.7
Price Date	2026-05-08
Ptbv Ratio	1.44
Relative Volume	0.23x
Revenue	50,018,481x
SBC By Revenue	85.9x
Share Based Comp	42,964,942
Tax By Revenue	-1.54x
Tr6m	-30.89%
Volume	542
Z Score	13.86

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0HB0 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0HB0 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0HB0?

Insider, institutional, and short-interest positioning.

Institutional ownership

+94.4%

Share of float held by funds and institutions

Insider ownership

+1.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0HB0 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.7

Neutral momentum band

Price vs 200-day MA

-15.2%

50/200-day relationship not available

Beta (5Y)

0.58

Less volatile than the market

Sharpe ratio

0.45

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0HB0

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0HB0 stock rating?

lon/0HB0 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0HB0 analysis?

The full report lives at /stocks/lon/0HB0/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0HB0?

The latest report frames lon/0HB0 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0HB0 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.